FSANZ notified approval β Galactosidase from (Enzyme)
Australia
Sep 01, 2021
This application seeks approval for a âβ-Galactosidase (EC 3.2.1.23)" enzyme derived from a genetically modified organism for use as processing aid in dairy food applications.
For further information (in English), click on the Link
CFSA opens consultation on amino acid management on medical foods
China
Sep 22, 2023
Lipase from Saccharomyces cerevisiae authorized for bakery use
Canada
Sep 18, 2023
Draft update to replace Food Regulations
Mauritius
Sep 12, 2023
EU - Food or Medicine? A European Regulatory Perspective on Nutritional Therapy Products to treat Inborn Errors of Metabolism
European Union
Sep 11, 2023
FSMA final rule on requirements for additional traceability records for certain foods
USA
Sep 08, 2023
FDA publishes lists of substances prohibited in food processing
Indonesia
Sep 07, 2023
FDA Warns of Potentially "Highly Toxic" Weight Loss Products
USA
Sep 05, 2023
Amended the list of products exempted from official controls at border control posts
European Union
Sep 04, 2023
New guidance on change management of allergen information
UK
Sep 04, 2023
FDA/EFSA - Regulatory and Safety Concerns Regarding the Use of Active Nanomaterials in Food Industry
USA
Aug 30, 2023
SAMR publishes implementing rules for health food evaluation
China
Aug 30, 2023
Regulation on Food Enzymes published in the Royal Gazette
Thailand
Aug 28, 2023
EU/Malaysian - Halal Meat, Food Fraud, and Consumer Protection: A Comparison of Islamic, European and Malaysian Perspectives
European Union
Aug 28, 2023
The first ever Codex Trust Fund group project closes with ambitious plans for future collaboration
Codex
Aug 28, 2023
Regulatory agenda topics for 2024 – 2025 published by ANVISA
Brazil
Aug 08, 2023
